Cyanobacteria blooms and non-alcoholic liver disease: evidence from a county level ecological study in the United States

被引:77
|
作者
Zhang, Feng [1 ]
Lee, Jiyoung [1 ,2 ,3 ]
Liang, Song [4 ,5 ]
Shum, C. K. [6 ,7 ]
机构
[1] Ohio State Univ, Environm Sci Grad Program, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Publ Hlth, Div Environm Hlth Sci, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA
[4] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL 32610 USA
[5] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA
[6] Ohio State Univ, Sch Earth Sci, Div Geodet Sci, Columbus, OH 43210 USA
[7] Chinese Acad Sci, Inst Geodesy & Geophys, Wuhan, Peoples R China
关键词
FRESH-WATER; MICROCYSTIN; PHYCOCYANIN; EUTROPHICATION; ASSOCIATION; PREVALENCE; TOXICITY; EXPOSURE; IMPACT; CANCER;
D O I
10.1186/s12940-015-0026-7
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Background: Harmful cyanobacterial blooms present a global threat to human health. There is evidence suggesting that cyanobacterial toxins can cause liver damage and cancer. However, because there is little epidemiologic research on the effects of these toxins in humans, the excess risk of liver disease remains uncertain. The purpose of this study is to estimate the spatial distribution of cyanobacterial blooms in the United States and to conduct a Bayesian statistical analysis to test the hypothesis that contamination from cyanobacterial blooms is a potential risk factor for non-alcoholic liver disease. Methods: An ecological study design was employed, in which county-specific gender and age standardized mortality rates (SMR) of non-alcoholic liver disease in the United States were computed between 1999 and 2010. Bloom coverage maps were produced based on estimated phycocyanin levels from MERIS (Medium Resolution Imaging Spectrometer) water color imageries from 08/01/2005 to 09/30/2005. A scan statistical tool was used to identify significant clusters of death from non-alcoholic liver disease. A map of local indicator of spatial association (LISA) clusters and a Bayesian spatial regression model were used to analyze the relationship between cyanobacterial bloom coverage and death from non-alcoholic liver disease. Results: Cyanobacterial blooms were found to be widely spread in the United States, including coastal areas; 62% of the counties (1949 out of 3109) showed signs of cyanobacterial blooms measured with MERIS. Significant clusters of deaths attributable to non-alcoholic liver disease were identified in the coastal areas impacted by cyanobacterial blooms. Bayesian regression analysis showed that bloom coverage was significantly related to the risk of non-alcoholic liver disease death. The risk from non-alcoholic liver disease increased by 0.3% (95% CI, 0.1% to 0.5%) with each 1% increase in bloom coverage in the affected county after adjusting for age, gender, educational level, and race. Conclusions: At the population level, there is a statistically significant association between cyanobacterial blooms and non-alcoholic liver disease in the contiguous United States. Remote sensing-based water monitoring provides a useful tool for assessing health hazards, but additional studies are needed to establish a specific association between cyanobacterial blooms and liver disease.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Non-alcoholic fatty liver disease and dairy products consumption: Results from FASA Persian cohort study
    Keshavarz, Zahra
    Rahimlou, Mehran
    Farjam, Mojtaba
    Homayounfar, Reza
    Khodadost, Mahmoud
    Abdollahi, Ashkan
    Tabrizi, Reza
    FRONTIERS IN NUTRITION, 2022, 9
  • [22] Non-alcoholic fatty liver disease is not independent risk factor for cardiovascular disease event: A cohort study
    Motamed, Nima
    Ajdarkosh, Hossein
    Ahmadi, Maral
    Perumal, Dhayaneethie
    Ashrafi, G. Hossein
    Nikkhah, Mehdi
    Faraji, Amir Hossein
    Maadi, Mansooreh
    Khoonsari, Mahmoodreza
    Rezaie, Nader
    Farahani, Behzad
    Tameshkel, Fahimeh Safarnezhad
    Ameli, Mitra
    Panahi, Mahshid
    Niya, Mohammad Hadi Karbalaie
    Zamani, Farhad
    WORLD JOURNAL OF HEPATOLOGY, 2020, 12 (06) : 323 - 331
  • [23] Non-alcoholic Fatty Liver Disease: Also a Disease of the Brain? A Systematic Review of the Preclinical Evidence
    Mikkelsen, Anne Catrine Daugaard
    Kjaergaard, Kristoffer
    Mookerjee, Rajeshwar Prosad
    Vilstrup, Hendrik
    Wegener, Gregers
    Bay-Richter, Cecilie
    Thomsen, Karen Louise
    NEUROCHEMICAL RESEARCH, 2024, 49 (06) : 1468 - 1488
  • [24] High parathyroid hormone level as a marker of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: A systematic review and meta-analysis
    Jaroenlapnopparat, Aunchalee
    Rittiphairoj, Thanitsara
    Chaisidhivej, Natapat
    Walker, Bradley
    Charoenngam, Nipith
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2023, 17 (08)
  • [25] The Incidence and Risk Factors of Non-Alcoholic Fatty Liver Disease: A Cohort Study from Iran
    Motamed, Nima
    Khonsari, Mahmoodreza
    Panahi, Mahshid
    Rezaie, Nader
    Maadi, Mansooreh
    Tameshkel, Fahimeh Safarnezhad
    Keyvani, Hossein
    Niya, Mohammad Hadi Karbalaie
    Ajdarkosh, Hossein
    Miri, Seyyed Mohammad
    Zamani, Farhad
    HEPATITIS MONTHLY, 2020, 20 (02)
  • [26] Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies
    Reddy, Yala K.
    Marella, Hemnishil K.
    Jiang, Yu
    Ganguli, Surosree
    Snell, Peter
    Podila, Pradeep S. B.
    Maliakkal, Benedict
    Satapathy, Sanjaya K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 10 (03) : 245 - 254
  • [27] Mean platelet volume for differentiating non-alcoholic fatty liver disease from non-alcoholic steatohepatitis: Is it ready for prime time?
    Madan, Kaushal
    Garg, Pallavi
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2023, 42 (02) : 156 - 157
  • [28] The relationship between Dyspepsia and Non-Alcoholic Fatty Liver Disease: A case-control study
    Shafiezadeh, Rasoul
    Saber, Seyed Saeid Esmaeili
    Alavian, Seyed Moayed
    Gholamiphesharaki, Mohammad
    Poorasar, Asie
    MEDICAL SCIENCE, 2020, 24 (102) : 587 - 593
  • [29] Impact of major depression and antidepressant use on alcoholic and non-alcoholic fatty liver disease: A population-based study
    Shaheen, Abdel Aziz
    Kaplan, Gilaad G.
    Sharkey, Keith A.
    Lethebe, Brendan Cord
    Swain, Mark G.
    LIVER INTERNATIONAL, 2021, 41 (10) : 2308 - 2317
  • [30] Serum level of free thyroxine is an independent risk factor for non-alcoholic fatty liver disease in euthyroid people
    Shao, Cuiping
    Cheng, Qiushi
    Zhang, Shuhui
    Xiang, Xinxin
    Xu, Youqing
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (02) : 655 - 662